Trifecta Capital Advisors, LLC Edwards Lifesciences Corp Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 300 shares of EW stock, worth $22,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$22,695
Previous $27.7 Million
28.56%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,350Shares Held
457MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.74 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.86 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.39 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.99 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$1.02 Billion0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.8B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...